The 2022 CSCO Academic Annual Conference Harbin Branch &The 7th Anti-Leukemia and Lymphoma International Summit Forum was grandly held!

Thinking, communicating, summarizing, and seeking development are the driving forces for the development of medicine, and they are also the habits
that doctors in the field of blood have adhered to for decades.
Although there was a pre-epidemic, it could not resist the pace
of their exchanges and discussions.
On November 10, 2022, Harbin Hematology was hosted by the Chinese Society of Clinical Oncology (CSCO), CSCO Leukemia Expert Committee and CSCO Lymphoma Expert Committee The "25th National Congress of Clinical Oncology 2022 CSCO Academic Annual Conference Harbin Branch, the 10th CSCO Leukemia and Lymphoma Expert Committee Academic Conference, the 7th Anti-Leukemia and Lymphoma International Summit Forum and CSCO Leukemia & Lymphoma Expert Committee Tour - Harbin Station" organized by the Cancer Institute and Peking University Cancer Hospital officially kicked off
.
The conference was held in a combination of online and offline format, Professor Shen Zhixiang of Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Professor Ma Jun of Harbin Institute of Hematology and Oncology, Professor Zhu Jun of Peking University Cancer Hospital, Professor Wu Depei of the First Affiliated Hospital of Soochow University, Professor Huang Xiaojun of Peking University People's Hospital, Professor Wang Jianxiang of Hematology Hospital of Chinese Academy of Medical Sciences, Professor Hu Yu, President of Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, served as the chairman of
the conference.

The conference set up a number of academic sessions such as academician forum, leukemia and lymphoma, lymphoma youth forum, leukemia youth forum, and drug regulatory policy (UCLI-CDE) session, and specially invited famous experts and scholars in the field of hematological oncology at home and abroad to discuss the cutting-edge progress and hot topics
in the fields of leukemia, lymphoma and myeloma.

Thinking and innovation, pioneering and leading, and going far

Academician Forum

Don't forget, China echoed, and the academician forum kicked off in an exciting video
.
At the beginning of the conference, under the chairmanship of Professor Ma Jun, Academician Zhang of the Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences, Professor Shen Zhixiang of Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, and Professor Zhu Jun of Peking University Cancer Hospital pointed out in their speeches that the field of hematological tumors in China has developed rapidly, and great breakthroughs have been made
in the field of genetic mechanism research and precision targeted therapy.
Nowadays, the epidemic is menacing, but can not stop the enthusiasm of fellow doctors for academic exchanges, this conference invited many top experts and scholars at home and abroad to give academic reports, providing an opportunity
for the majority of doctors to learn and communicate.
It is believed that taking this opportunity will surely gather insights, stimulate academic innovation, and make positive contributions
to the development of oncology in China and the construction of a healthy China.

After the speech, the academic report of the academician forum officially began
.
Standardization, precision and innovation are the vision of precision oncology, leading China's top experts in basic medicine, oncology, biomedicine and other fields, Academician Yu Jinming, Academician Yu Jinming of Shandong Cancer Hospital, Academician Wang Xiaodong of Beijing Institute of Life Sciences, Academician Fan Jia of Zhongshan Hospital Affiliated to Fudan University, and Academician Xu Binghe of Cancer Hospital of Chinese Academy of Medical Sciences respectively started from the precise targeted treatment of leukemia - arsenic trioxide, new practice of precision oncology, The application and evolution of BTK inhibitors, the progress of surgical treatment technology and strategy of liver cancer, and the current situation and challenges of China's research and development of new anti-tumor drugs have brought an academic feast to colleagues across the country, and the academic atmosphere is very strong
.

Professor Ma Jun presided over the meeting

Professor Shen Zhixiang delivered a speech

Academician Zhang delivered a speech

Academician Zhang gave a keynote speech

Academician Yu Jinming gave a keynote speech

Academician Wang Xiaodong gave a keynote speech

Academician Fan Jia gave a keynote speech

Academician Xu Binghe gave a keynote speech

Exchange and learn from each other, brainstorm and plan for the future

Leukemia and lymphoma session

There were 3 leukemia and lymphoma sessions at the conference, and 2 sessions were held
on November 10.
Professor Ma Jun introduced at the beginning that the leukemia and lymphoma session brought together well-known hematology experts at home and abroad, such as global lymphoma experts Professor Owen A.
O'Connor and Professor Franco Cavalli to participate online, and everyone was full of enthusiasm, and more than 4,000 visitors participated
online at the beginning of the conference 。 Professor Zhu Jun said in his speech that although due to the impact of the epidemic, the meeting carefully prepared by Professor Ma Jun and the staff of Harbin Institute of Hematology and Oncology can only be held online and offline, but I am glad that experts and scholars at home and abroad have participated in the conference online, and I believe that with the common attention and support of experts in the field of hematology across the country, the conference will be a complete success
.

Under the chairmanship of Professor Ma Jun, Professor Zhu Jun, Professor Huang Huiqiang and Professor Su Liping, Professor Liu Weiping of Peking University Cancer Hospital, Professor Song Yuqin of Peking University Cancer Hospital, Professor Bai Ou of Bethune First Hospital of Jilin University, Professor Zhang Huilai of Tianjin Medical University Cancer Hospital, and Professor Xu Wei of the First Affiliated Hospital of Nanjing Medical University gave keynote speeches
respectively.
The professors said that the disease burden of lymphoma in China continues to increase, and 13,032 cases of lymphoma have been uploaded to the standard database and preliminary analysis results
have been obtained.
Through the analysis of lymphoma big data, it can accurately guide the standardized diagnosis and treatment in various regions, strongly support the revision and formulation of industry guidelines, and also help carry out real-world research and explore new targets, thereby promoting the research and development
of new drugs.

At this special conference on leukemia and lymphoma, 2 internationally renowned lymphoma experts participated online
.
With rich experience in the field of peripheral T-cell lymphoma, Professor Owen A.
O'Connor from the University of Virginia Comprehensive Cancer Center gave a wonderful report
on the development status and challenges of peripheral T-cell lymphoma treatment, and the new drugs and directions that can be explored.
Another international lymphoma celebrity, Professor Franco Cavalli of the Institute of Oncology of Southern Switzerland, introduced the treatment progress of aggressive lymphoma, including the precise treatment of DLBCL under the guidance of genotyping
.
Finally, he said that he looked forward to all colleagues attending Lugano to participate in the 2023 International Malignant Lymphoma Conference!

Experts gave wonderful presentations

Start with the end and set sail

The conference gathered big coffee, the content of the conference was wonderful, which effectively promoted the academic exchanges and discipline development in the fields of leukemia and lymphoma in China, improved the level of tumor diagnosis and treatment, and also promoted the standardization, precision and individualization of tumor treatment
.
Professor Ma Jun also earnestly hopes that the vast number of workers in the field of blood can be realistic and pragmatic and make China's contribution
to the world's anti-cancer work.
In addition, there were also lymphoma youth forum and leukemia youth forum at this conference, and young and middle-aged experts carried out in-depth exchanges and discussions
on their own fields.
Tomorrow, there will be a special session on leukemia and lymphoma, a special session on children's hematology, a forum on tumor-related anemia, a special session on UCLI-CDE, etc.
, and we sincerely invite all experts in the field of blood to participate in the conference and continue to pay attention to follow-up reports
.